Serology test market size was valued at $6.5 billion in 2025 and is projected to reach $10.6 billion by 2035, expanding at a CAGR of 5.2% during 2026–2035. The market growth is driven by increasing prevalence of infectious diseases, expanding diagnostic infrastructure, and rising demand for cost-effective screening solutions. According to the World Health Organization (WHO), infectious diseases such as hepatitis, HIV, and dengue continue to pose a significant global health burden. WHO estimates that over 350 million people live with chronic hepatitis infections, while HIV affects nearly 39 million individuals globally. Additionally, dengue infections are rising rapidly, with up to 400 million cases annually, emphasizing the need for scalable diagnostic testing.
Serology testing plays a critical role in identifying antibodies, enabling disease detection, immunity assessment, and epidemiological surveillance. The increasing adoption of immunoassay technologies across hospitals, diagnostic laboratories, and public health programs is supporting market expansion. Moreover, regulatory bodies such as the U.S. Food and Drug Administration (FDA) are actively supporting innovation in antibody-based diagnostics, further accelerating product development and commercialization.
Rising Global Burden of Infectious Diseases Driving Market Growth
The increasing prevalence of infectious diseases remains the primary growth driver for the serology test market. According to WHO, infectious diseases account for a significant proportion of global mortality, particularly in low- and middle-income countries. The growing incidence of vector-borne diseases such as dengue and malaria has increased demand for rapid and reliable antibody-based testing solutions.
Government-led screening initiatives and vaccination programs are further boosting demand. For instance, WHO immunization programs have expanded significantly, increasing the need for serological testing to monitor immune responses. Additionally, the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) highlights growing investments in vaccine development, which require serology testing for clinical validation.
In 2025–2026, leading companies such as Roche, Abbott, and Siemens Healthineers are focusing on expanding immunoassay menus and improving assay sensitivity. These strategies aim to enhance diagnostic accuracy and expand applications beyond infectious diseases into autoimmune and oncology testing.
High Cost and Limited Accessibility as Key Market Challenges
Despite steady growth, the serology testing market faces challenges related to cost, accessibility, and infrastructure limitations. Advanced immunoassay platforms such as CLIA systems require significant capital investment, limiting adoption in resource-constrained regions.
Supply chain disruptions and raw material dependencies also impact production and distribution. According to the U.S. FDA, shortages of diagnostic reagents and laboratory supplies have affected testing capacity in several regions. Additionally, variability in test accuracy and cross-reactivity issues can impact diagnostic reliability, particularly in rapid test kits.
To address these challenges, companies are investing in cost-effective testing solutions and localized manufacturing. The development of portable and point-of-care serology tests is improving accessibility, especially in emerging markets. Furthermore, collaborations between public health organizations and diagnostic manufacturers are helping expand testing coverage globally.
Market Segmentation
Segment Analysis: Consumables & Kits Segment Leads the Market
The consumables & kits segment dominates the serology test market due to its recurring revenue model and high usage volume. These products are essential for routine diagnostic testing, particularly in infectious disease screening programs.
The demand is driven by increasing test volumes in hospitals and diagnostic laboratories. Companies such as Roche and Abbott have expanded their reagent portfolios to support a wide range of serological assays. Between 2022 and 2026, manufacturers have focused on developing high-sensitivity antibody kits to improve diagnostic accuracy and reduce turnaround time.
Lateral Flow Assay (Rapid Tests) Segment to Record Strong Growth
The rapid tests segment is expected to witness the fastest growth due to its ease of use, portability, and cost-effectiveness. These tests are widely used in point-of-care settings and remote areas with limited laboratory infrastructure.
Technological advancements in lateral flow assays have improved sensitivity and specificity, enabling broader adoption. Increasing investments in decentralized diagnostics and home testing solutions are further driving growth. Governments and healthcare organizations are promoting rapid testing to enhance disease surveillance and outbreak management.
The global serology test market is geographically segmented into North America (the US and Canada), Europe (the UK, Germany, France, Italy, Spain, Russia, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, Australia and New Zealand, ASEAN Countries, and the Rest of Asia-Pacific), and the Rest of the World (the Middle East & Africa and Latin America).
United States Leads the Market
The United States dominates the serology test market due to advanced healthcare infrastructure and strong investment in diagnostics. According to the U.S. FDA, the country has a well-established regulatory framework that supports rapid approval and commercialization of diagnostic tests.
Additionally, the Centers for Disease Control and Prevention (CDC) highlights the increasing burden of infectious diseases and the need for large-scale screening programs. The presence of major diagnostic companies and continuous technological innovation further strengthen the market position.
India to Record Strong Growth
India is expected to witness significant growth due to expanding healthcare infrastructure and increasing disease burden. According to WHO, India accounts for a large share of global infectious disease cases, including tuberculosis and hepatitis.
Government initiatives such as national health programs and increased diagnostic spending are driving market growth. Additionally, the expansion of local manufacturing and adoption of cost-effective testing solutions are improving accessibility in rural and urban areas.
Competitive Landscape
The serology test market is highly competitive, characterized by the presence of global diagnostic leaders and regional manufacturers. Companies such as F. Hoffmann-La Roche Ltd, Abbott Laboratories, Siemens Healthineers AG, Danaher Corporation (Beckman Coulter), and DiaSorin S.p.A. dominate the market through strong product portfolios and global distribution networks. These players are focusing on innovation, expanding assay menus, and enhancing automation capabilities to maintain their competitive edge.
Recent Developments
The Report Covers
1.1 Research Methodology
1.2 Market Snapshot
2.1 Scope of the Study
2.2 Analyst Insight & Current Market Trends
2.2.1 Key Serology Test Market Trends
2.2.2 Market Recommendations
2.3 Porter's Five Forces Analysis for the Serology Test Market
2.3.1 Competitive Rivalry
2.3.2 Threat of New Entrants
2.3.3 Bargaining Power of Suppliers
2.3.4 Bargaining Power of Buyers
2.3.5 Threat of Substitutes
3.1 Market Drivers
3.1.1 Drivers For Global Serology Test Market: Impact Analysis
3.2 Market Pain Points and Challenges
3.2.1 Restraints For Global Serology Test Market: Impact Analysis
3.3 Market Opportunities
3.3.1 Opportunities For Global Serology Test Market: Impact Analysis
4.1 Competitive Dashboard – Serology Test Market Revenue and Share by Manufacturers
4.2 Key Company Analysis
4.2.1 F. Hoffmann-La Roche Ltd
4.2.1.1 Overview
4.2.1.2 Product Portfolio
4.2.1.3 Financial Analysis
4.2.1.4 SWOT Analysis
4.2.1.5 Business Strategy
4.2.2 Abbott Laboratories
4.2.2.1 Overview
4.2.2.2 Product Portfolio
4.2.2.3 Financial Analysis
4.2.2.4 SWOT Analysis
4.2.2.5 Business Strategy
4.2.3 Siemens Healthineers AG
4.2.3.1 Overview
4.2.3.2 Product Portfolio
4.2.3.3 Financial Analysis
4.2.3.4 SWOT Analysis
4.2.3.5 Business Strategy
4.2.4 Danaher Corporation (Beckman Coulter)
4.2.4.1 Overview
4.2.4.2 Product Portfolio
4.2.4.3 Financial Analysis
4.2.4.4 SWOT Analysis
4.2.4.5 Business Strategy
4.2.5 DiaSorin S.p.A.
4.2.5.1 Overview
4.2.5.2 Product Portfolio
4.2.5.3 Financial Analysis
4.2.5.4 SWOT Analysis
4.2.5.5 Business Strategy
4.3 Top Winning Strategies by Market Players
4.3.1 Merger and Acquisition
4.3.2 Product Launch
4.3.3 Partnership And Collaboration
5.1 Instruments
5.2 Consumables & Kits
5.3 Software & Services
6.1 Enzyme-Linked Immunosorbent Assay (ELISA)
6.2 Chemiluminescence Immunoassay (CLIA)
6.3 Lateral Flow Assay (Rapid Tests)
6.4 Neutralization Assays
6.5 Multiplex Immunoassays
6.6 Radioimmunoassay (RIA)
7.1 Infectious Diseases
7.2 Autoimmune Diseases
7.3 Allergy Testing
7.4 Oncology
7.5 Others
8.1 North American Serology Test Market Sales Analysis – Product Type | Technology | Application ($ Million)
8.1.1 United States
8.1.2 Canada
8.2 European Serology Test Market Sales Analysis – Product Type | Technology | Application ($ Million)
8.2.1 UK
8.2.2 Germany
8.2.3 Italy
8.2.4 Spain
8.2.5 France
8.2.6 Russia
8.2.7 Rest of Europe
8.3 Asia-Pacific Serology Test Market Sales Analysis – Product Type | Technology | Application ($ Million)
8.3.1 China
8.3.2 Japan
8.3.3 South Korea
8.3.4 India
8.3.5 Australia & New Zealand
8.3.6 ASEAN Countries
8.3.7 Rest of Asia-Pacific
8.4 Rest of the World Serology Test Market Sales Analysis – Product Type | Technology | Application ($ Million)
8.4.1 Latin America
8.4.2 Middle East and Africa
9.1 Abbexa Ltd.
9.1.1 Quick Facts
9.1.2 Company Overview
9.1.3 Product Portfolio
9.1.4 Business Strategies
9.2 Agilent Technologies Inc.
9.2.1 Quick Facts
9.2.2 Company Overview
9.2.3 Product Portfolio
9.2.4 Business Strategies
9.3 Becton Dickinson and Company
9.3.1 Quick Facts
9.3.2 Company Overview
9.3.3 Product Portfolio
9.3.4 Business Strategies
9.4 bioMérieux SA
9.4.1 Quick Facts
9.4.2 Company Overview
9.4.3 Product Portfolio
9.4.4 Business Strategies
9.5 Bio-Rad Laboratories Inc.
9.5.1 Quick Facts
9.5.2 Company Overview
9.5.3 Product Portfolio
9.5.4 Business Strategies
9.6 Creative Diagnostics
9.6.1 Quick Facts
9.6.2 Company Overview
9.6.3 Product Portfolio
9.6.4 Business Strategies
9.7 CTK Biotech Inc.
9.7.1 Quick Facts
9.7.2 Company Overview
9.7.3 Product Portfolio
9.7.4 Business Strategies
9.8 DRG International Inc.
9.8.1 Quick Facts
9.8.2 Company Overview
9.8.3 Product Portfolio
9.8.4 Business Strategies
9.9 EUROIMMUN AG (PerkinElmer)
9.9.1 Quick Facts
9.9.2 Company Overview
9.9.3 Product Portfolio
9.9.4 Business Strategies
9.10 Mindray Bio-Medical Electronics
9.10.1 Quick Facts
9.10.2 Company Overview
9.10.3 Product Portfolio
9.10.4 Business Strategies
9.11 NovaTec Immundiagnostica GmbH
9.11.1 Quick Facts
9.11.2 Company Overview
9.11.3 Product Portfolio
9.11.4 Business Strategies
9.12 PerkinElmer Inc.
9.12.1 Quick Facts
9.12.2 Company Overview
9.12.3 Product Portfolio
9.12.4 Business Strategies
9.13 QuidelOrtho Corporation
9.13.1 Quick Facts
9.13.2 Company Overview
9.13.3 Product Portfolio
9.13.4 Business Strategies
9.14 Randox Laboratories Ltd.
9.14.1 Quick Facts
9.14.2 Company Overview
9.14.3 Product Portfolio
9.14.4 Business Strategies
9.15 SD Biosensor
9.15.1 Quick Facts
9.15.2 Company Overview
9.15.3 Product Portfolio
9.15.4 Business Strategies
9.16 Snibe
9.16.1 Quick Facts
9.16.2 Company Overview
9.16.3 Product Portfolio
9.16.4 Business Strategies
9.17 Sysmex Corporation
9.17.1 Quick Facts
9.17.2 Company Overview
9.17.3 Product Portfolio
9.17.4 Business Strategies
9.18 Tecan Group Ltd.
9.18.1 Quick Facts
9.18.2 Company Overview
9.18.3 Product Portfolio
9.18.4 Business Strategies
9.19 Thermo Fisher Scientific Inc.
9.19.1 Quick Facts
9.19.2 Company Overview
9.19.3 Product Portfolio
9.19.4 Business Strategies
9.20 Wondfo Biotech Co., Ltd.
9.20.1 Quick Facts
9.20.2 Company Overview
9.20.3 Product Portfolio
9.20.4 Business Strategies
1. Global Serology Test Market Research and Analysis by Product Type, 2025–2035 ($ Million)
2. Global Serology Test Instruments Market Research and Analysis by Region, 2025–2035 ($ Million)
3. Global Serology Test Consumables & Kits Market Research and Analysis by Region, 2025–2035 ($ Million)
4. Global Serology Test Software & Services Market Research and Analysis by Region, 2025–2035 ($ Million)
5. Global Serology Test Market Research and Analysis by Technology, 2025–2035 ($ Million)
6. Global Enzyme-Linked Immunosorbent Assay (ELISA) Serology Test Market Research and Analysis by Region, 2025–2035 ($ Million)
7. Global Chemiluminescence Immunoassay (CLIA) Serology Test Market Research and Analysis by Region, 2025–2035 ($ Million)
8. Global Lateral Flow Assay (Rapid Tests) Serology Test Market Research and Analysis by Region, 2025–2035 ($ Million)
9. Global Neutralization Assays Serology Test Market Research and Analysis by Region, 2025–2035 ($ Million)
10. Global Multiplex Immunoassays Serology Test Market Research and Analysis by Region, 2025–2035 ($ Million)
11. Global Radioimmunoassay (RIA) Serology Test Market Research and Analysis by Region, 2025–2035 ($ Million)
12. Global Serology Test Market Research and Analysis by Application, 2025–2035 ($ Million)
13. Global Serology Test Market Size for Infectious Diseases Research and Analysis by Region, 2025–2035 ($ Million)
14. Global Serology Test Market Size for Autoimmune Diseases Research and Analysis by Region, 2025–2035 ($ Million)
15. Global Serology Test Market Size for Allergy Testing Research and Analysis by Region, 2025–2035 ($ Million)
16. Global Serology Test Market Size for Oncology Research and Analysis by Region, 2025–2035 ($ Million)
17. Global Serology Test Market Size for Others Research and Analysis by Region, 2025–2035 ($ Million)
18. Global Serology Test Market Research and Analysis by Region, 2025–2035 ($ Million)
19. North America Serology Test Market Research and Analysis by Country, 2025–2035 ($ Million)
20. North America Serology Test Market Research and Analysis by Product Type, 2025–2035 ($ Million)
21. North America Serology Test Market Research and Analysis by Technology, 2025–2035 ($ Million)
22. North America Serology Test Market Research and Analysis by Application, 2025–2035 ($ Million)
23. Europe Serology Test Market Research and Analysis by Country, 2025–2035 ($ Million)
24. Europe Serology Test Market Research and Analysis by Product Type, 2025–2035 ($ Million)
25. Europe Serology Test Market Research and Analysis by Technology, 2025–2035 ($ Million)
26. Europe Serology Test Market Research and Analysis by Application, 2025–2035 ($ Million)
27. Asia-Pacific Serology Test Market Research and Analysis by Country, 2025–2035 ($ Million)
28. Asia-Pacific Serology Test Market Research and Analysis by Product Type, 2025–2035 ($ Million)
29. Asia-Pacific Serology Test Market Research and Analysis by Technology, 2025–2035 ($ Million)
30. Asia-Pacific Serology Test Market Research and Analysis by Application, 2025–2035 ($ Million)
31. Rest of the World Serology Test Market Research and Analysis by Region, 2025–2035 ($ Million)
32. Rest of the World Serology Test Market Research and Analysis by Product Type, 2025–2035 ($ Million)
33. Rest of the World Serology Test Market Research and Analysis by Technology, 2025–2035 ($ Million)
34. Rest of the World Serology Test Market Research and Analysis by Application, 2025–2035 ($ Million)
1. Global Serology Test Market Share by Product Type, 2025 Vs 2035 (%)
2. Global Serology Test Instruments Research and Analysis by Region, 2025 Vs 2035 (%)
3. Global Serology Test Consumables & Kits Research and Analysis by Region, 2025 Vs 2035 (%)
4. Global Serology Test Software & Services Research and Analysis by Region, 2025 Vs 2035 (%)
5. Global Serology Test Market Share by Technology, 2025 Vs 2035 (%)
6. Global Enzyme-Linked Immunosorbent Assay (ELISA) Serology Test Research and Analysis by Region, 2025 Vs 2035 (%)
7. Global Chemiluminescence Immunoassay (CLIA) Serology Test Research and Analysis by Region, 2025 Vs 2035 (%)
8. Global Lateral Flow Assay (Rapid Tests) Serology Test Research and Analysis by Region, 2025 Vs 2035 (%)
9. Global Neutralization Assays Serology Test Research and Analysis by Region, 2025 Vs 2035 (%)
10. Global Multiplex Immunoassays Serology Test Research and Analysis by Region, 2025 Vs 2035 (%)
11. Global Radioimmunoassay (RIA) Serology Test Research and Analysis by Region, 2025 Vs 2035 (%)
12. Global Serology Test Market Share by Application, 2025 Vs 2035 (%)
13. Global Serology Test Market Size for Infectious Diseases Research and Analysis by Region, 2025 Vs 2035 (%)
14. Global Serology Test Market Size for Autoimmune Diseases Research and Analysis by Region, 2025 Vs 2035 (%)
15. Global Serology Test Market Size for Allergy Testing Research and Analysis by Region, 2025 Vs 2035 (%)
16. Global Serology Test Market Size for Oncology Research and Analysis by Region, 2025 Vs 2035 (%)
17. Global Serology Test Market Size for Others Research and Analysis by Region, 2025 Vs 2035 (%)
18. Global Serology Test Market Share by Region, 2025 Vs 2035 (%)
19. United States Serology Test Market Size, 2025–2035 ($ Million)
20. Canada Serology Test Market Size, 2025–2035 ($ Million)
21. UK Serology Test Market Size, 2025–2035 ($ Million)
22. France Serology Test Market Size, 2025–2035 ($ Million)
23. Germany Serology Test Market Size, 2025–2035 ($ Million)
24. Italy Serology Test Market Size, 2025–2035 ($ Million)
25. Spain Serology Test Market Size, 2025–2035 ($ Million)
26. Russia Serology Test Market Size, 2025–2035 ($ Million)
27. India Serology Test Market Size, 2025–2035 ($ Million)
28. China Serology Test Market Size, 2025–2035 ($ Million)
29. Japan Serology Test Market Size, 2025–2035 ($ Million)
30. South Korea Serology Test Market Size, 2025–2035 ($ Million)
31. Australia & New Zealand Serology Test Market Size, 2025–2035 ($ Million)
32. ASEAN Serology Test Market Size, 2025–2035 ($ Million)
33. Rest of Asia-Pacific Serology Test Market Size, 2025–2035 ($ Million)
34. Latin America Serology Test Market Size, 2025–2035 ($ Million)
35. Middle East & Africa Serology Test Market Size, 2025–2035 ($ Million)